Real World Evidence (RWE) 

Press Release: The Academy of Managed Care Pharmacy (AMCP) Foundation fulfilled a significant part of its philanthropic mission last month with two successful giving campaigns

Press Release: While improved adherence to diabetes medications is associated with higher drug costs, it also is associated with lower inpatient, outpatient and emergency room costs, according to a study in this month’s Journal of Managed Care & Specialty Pharmacy (JMCP).

In January 2017, AMCP co-sponsored a conference with the PhRMA Foundation on the use of CER and PCOR by patients, clinicians, and payers. The conference centered on existing strategies to enhance uptake and use of CER/PCOR, as well as the needs and gaps in the uptake and use of CER/PCOR evidence.

Press Release: A comprehensive medication management program designed to optimize therapy and boost adherence to hepatitis C virus (HCV) medications saved a state Medicaid program nearly $3.8 million in avoided costs, according to a new study in the Journal of Managed Care & Specialty Pharmacy (JMCP).

Press Release: Variations in how biosimilar products are named may affect the willingness of some pharmacists to substitute an interchangeable biologic for its branded reference product, according to a survey study published in this month’s Journal of Managed Care & Specialty Pharmacy (JMCP).

Presentation developed by AMCP in 2016.

Press Release: The current issue of the Journal of Managed Care & Specialty Pharmacy (JMCP) features valuable new research on the practice of medication therapy management (MTM) and related pharmacist interventions, topics that to date have remained relatively understudied.

Presentation developed by AMCP in February 2015.

AMCP webinar that reviewed the AMCP Research Prioritization project.

This glossary defines or describes terminology used in comparative clinical effectiveness research for managed care pharmacy professionals. For cost effectiveness terminology, please see other resources, such as Health Care Cost, Quality, and Outcomes: ISPOR Book of Terms. Lawrenceville, NJ: International Society for Pharmacoeconomics and Outcomes Research; 2003.